Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Sensus Healthcare (SRTS) over the last 9 years, with Q3 2025 value amounting to $200223.0.

  • Sensus Healthcare's Gains from Investment Securities fell 3217.91% to $200223.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $200223.0, marking a year-over-year decrease of 3217.91%. This contributed to the annual value of $195223.0 for FY2024, which is 3762.31% down from last year.
  • As of Q3 2025, Sensus Healthcare's Gains from Investment Securities stood at $200223.0, which was down 3217.91% from $200223.0 recorded in Q2 2025.
  • Sensus Healthcare's 5-year Gains from Investment Securities high stood at $12.8 million for Q1 2022, and its period low was -$116000.0 during Q1 2024.
  • For the 5-year period, Sensus Healthcare's Gains from Investment Securities averaged around $918214.3, with its median value being $214778.5 (2021).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 547222.22% in 2022, then crashed by 22953.66% in 2024.
  • Sensus Healthcare's Gains from Investment Securities (Quarter) stood at $46000.0 in 2021, then skyrocketed by 2276.09% to $1.1 million in 2022, then tumbled by 71.87% to $307473.0 in 2023, then crashed by 64.87% to $108000.0 in 2024, then surged by 85.39% to $200223.0 in 2025.
  • Its last three reported values are $200223.0 in Q3 2025, $200223.0 for Q2 2025, and -$36000.0 during Q1 2025.